Table: Pharmarise Holdings -Q1 group results

Pharmarise Holdings

13/10/2022 09:30

Oct 13 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Aug 31, 2022        Aug 31, 2021     May 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               12.86               13.06            51.91    
                   (-1.5 pct)          (+1.4 pct)       (+0.6 pct)  
  Operating          348 mln             317 mln            1.61    
                   (+9.7 pct)                           (+5.7 pct)  
  Recurring          341 mln             335 mln            1.56    
                   (+1.8 pct)                           (+2.9 pct)  
  Net                111 mln             63 mln           543 mln   
                   (+75.0 pct)                          (+21.4 pct) 
  EPS               11.88 yen           6.83 yen         58.07 yen  
  EPS Diluted       8.99 yen            5.18 yen                    
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div                                  NIL              NIL     
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T